Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Fate Therapeutics (FATE)

NASDAQ:FATE

FATE

Fate Therapeutics

RESEARCH TOOLSreports

Fate Therapeutics (FATE) Stock News & Sentiment

Compare

1,263 Followers

Premium

Ratings

Maintaining a Hold on Fate Therapeutics as FT819’s Clinical and Commercial Profile Remains Unclear

24d ago

FATE

Premium

Company Announcements

Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts

4M ago

FATE

Premium

Company Announcements

Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks

4M ago

FATE

Premium

Ratings

Fate Therapeutics: Balancing Potential and Uncertainty with FT819’s Promise in Autoimmune Treatment

4M ago

FATE

Premium

Pre-Earnings

Is FATE a Buy, Before Earnings?

5M ago

FATE

Premium

Company Announcements

Fate Therapeutics Advances CAR T-Cell Therapy with New Clinical Study

5M ago

FATE

Premium

Company Announcements

Fate Therapeutics’ Phase 1 Study: A Potential Game-Changer in Autoimmune Disease Treatment

5M ago

FATE

More FATE News >

FATE News on the Web

2026-03-04

Bank of America Securities Sticks to Their Hold Rating for Fate Therapeutics (FATE)

TipRanks News

Neutral

2026-02-27

Maintaining a Hold on Fate Therapeutics as FT819’s Clinical and Commercial Profile Remains Unclear

TipRanks News

Neutral

2026-02-26

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX) and Fate Therapeutics (FATE)

TipRanks News

Bearish

2026-02-26

Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates

Zacks

Neutral

2026-02-26

Fate Therapeutics reports Q4 EPS (77c), consensus (27c)

TipRanks News

Bullish

2026-01-16

Why Fate Therapeutics, Inc.’s (FATE) Stock Is Up 6.19%

AAII

Neutral

2026-01-13

Top Fate Therapeutics Insider Makes a Quiet Move That Investors Can’t Ignore

TipRanks News

Bearish

2026-01-08

Why Fate Therapeutics, Inc.’s (FATE) Stock Is Down 5.41%

AAII

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FATE’s Media Buzz Sentiment?

Currently, no data Available

What is FATE’s weekly average amount of articles?

Currently, no data Available

What is FATE’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

KHTRFKnight Therapeutics

KMTSKestra Medical Technologies Ltd.

OVIDOvid Therapeutics

PYPDPolyPid

BCYCBicycle Therapeutics

Showing the stocks with the most bullish news sentiment over the past week